₹74 Medicine Carrying an MRP of ₹4,981: UP Hospital Pharmacies Under Scrutiny Over Wide Price Gaps
Important Regulatory Update for Pharmacy Professionals & Students
A recent state-wide inspection by the Uttar Pradesh Food Safety and Drug Administration (FSDA) has brought renewed attention to pharmaceutical pricing ethics, transparency, and pharmacy compliance. The inspection covered 214 pharmacies attached to medical colleges and private hospitals across 17 districts, evaluating the massive gaps between procurement prices and printed Maximum Retail Prices (MRP).
Overview of the FSDA Inspection
| Key Highlights of the UP FSDA Investigation | |
|---|---|
| Conducting Authority | Uttar Pradesh Food Safety and Drug Administration (FSDA) |
| Scope of Inspection | 214 pharmacies across 17 districts (Private Hospitals & Medical Colleges) |
| Scope of Analysis | Analyzed pricing and billing chains for 130 critical medicines and injections. |
| Major Findings | 36 medicines had MRPs more than 10 times their procurement prices. In one case, the difference reached nearly 67 times. |
| Quality Testing | Separate inspections in Lucknow resulted in the collection of 38 medicine samples for quality testing. |
Substantial Price Discrepancies Identified
The officials reviewed the complete pricing chain—from the manufacturer’s printed MRP and the pharmacy’s procurement price to the final amount billed to patients. Below is the detailed breakdown of the massive price gaps found in life-saving and critical care medicines:
| Medicine / Device Name | Reported Procurement Price | Printed MRP | Approximate Difference |
|---|---|---|---|
| Polymyxin-B Injection (GUFIPOL 500,000 Units) | ₹74.09 | ₹4,980.94 | ~67 times (₹4,906.85 margin/unit) |
| Polymyxin-B Injection (GUFIPOL 5 Lakh Units – Variant Pack) | ₹90.00 | ₹4,528.10 | ~50 times |
| Colistimethate Sodium 4.5 MIU | ₹210.00 | ₹9,702.31 | ~46 times |
| Tigecycline 50 mg Injection | ₹154.54 | ₹7,110.47 | ~46 times |
| Terlipressin Injection | ₹56.00 | ₹3,050.00 | ~54 times |
| Bevacizumab 400 mg | ₹7,541.10 | ₹69,995.00 | ~9.2 times |
| Meropenem 1 g (Various Brands) | – | – | 5.31 to 9.98 times |
| Medical Device: Three-way Stopcock | ₹6.40 | ₹163.00 | >25 times |
Why This Matters to Pharmacists & Patients
A high MRP does not inherently establish illegal overcharging, as discounts, taxes, and distribution arrangements affect final pricing. However, such unusually large differences between procurement prices, printed MRPs, and final patient billing highlight the immediate need for transparent pricing and proper documentation throughout the pharmaceutical supply chain.
Pharmacy Compliance & Record-Keeping Examined
For pharmacy students and working professionals, it is vital to note that the state-wide campaign examined far more than just pricing. Officials rigorously checked statutory compliance mandated for operating hospital pharmacies.
| Crucial Pharmacy Operations & Records Checked by FSDA |
|---|
|
Uttar Pradesh Moves Towards Greater Price Transparency
Following this scrutiny, the Uttar Pradesh FSDA has established new directives aimed at improving public disclosure of medicine-related information in hospital settings. Regulatory action will be taken based on findings and responses from hospitals, suppliers, and manufacturers.
| New Disclosure Directives for Hospital Pharmacies | |
|---|---|
| Public Transparency Rules | Hospital pharmacies and in-patient pharmacies must publicly disclose critical pricing and product information. |
| Mandatory Data to Disclose |
|
| Retail Pharmacy Obligations | Must publicly display their drug licence details, the name of the registered pharmacist, and update stock information periodically. |
| Goal of Initiative | To improve consumer awareness and price transparency rather than functioning as a direct price-control mechanism. |
Reference & Official Information
This post serves as an educational awareness update for pharmacy aspirants and professionals to understand regulatory audits, supply chain ethics, and compliance standards. Always ensure strict adherence to the Drugs and Cosmetics Act and standard pharmacy operating procedures.
